Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BISE: Benralizumab in mild to moderate persistent asthma
NCT02322775Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2015
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Feb 2015; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02322775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322775.